# OnCo record sgm-101 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/sgm-101/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "sgm-101" ;
  schema:name "SGM-101"@en ;
  schema:description "SGM-101 is an experimental monoclonal antibody from Surgimab in phase 3 trials for colorectal cancer, aimed at CEACAM5."@en ;
  schema:url <https://onco.cc/drugs/sgm-101/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=SGM-101> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:targets <https://onco.cc/targets/ceacam5/> ;
  onco:companies <https://onco.cc/companies/surgimab/> ;
  onco:trials <https://onco.cc/trials/nct03659448/> .